Positive high-level results from a planned interim analysis of the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab demonstrated a statistically significant and highly ...
AstraZeneca said on Tuesday its cancer drug Imfinzi combined with Amgen's targeted immunotherapy Imdelltra ...
It's a tool that every camper should have on them at all times.
Company invited to present alongside global pharmaceutical, biotechnology and industry leaders at five high-profile U.S. and China conferences in September ...
Matt Spiegel discusses the life and legacy of former Bears fullback Matt Suhey, who died at 68 after a 10-year career with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results